| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e094ef9f5a502a075764a8c13f15fb44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
1977-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1979-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd779ee6712226b3361693cdd3c87404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3e48b40bc422ec915fe024426d9c091 |
| publicationDate |
1979-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4146613-A |
| titleOfInvention |
Oral anti-diabetic drug composition |
| abstract |
There is provided an anti-diabetic drug to be taken orally. This drug comprises a sulfonyl urea and a kinin in retarded form. The kinin may be a Brady kinin or kallidin and is used in retarded form in an amount of from about 10μ grams to about 20 milligrams per unit dosage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008011713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9839678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364521-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010008899-A1 |
| priorityDate |
1976-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |